Kilo-scale synthesis process for 2'-O-(2-methoxyethyl)-pyrimidine derivatives

Area of Science:

• Organic Chemistry
• Medicinal Chemistry
• Nucleoside Chemistry

Background:

• Efficient synthesis of modified nucleosides is crucial for developing antiviral and anticancer drugs.
• 2 -O-(2-methoxyethyl)-pyrimidines are important building blocks for oligonucleotide synthesis.
• Existing production methods for these compounds can be inefficient and costly.

Purpose of the Study:

• To develop an improved and scalable process for producing 2 -O-(2-methoxyethyl)-5-methyluridine and its cytidine analog.
• To optimize key reaction steps including ring-opening, dimethoxytritylation, and benzoylation.
• To enhance the overall yield and purity of the target nucleoside analogs.

Main Methods:

• Modified ring-opening reaction conditions using O-2,2 -anhydro-5-methyluridine and tris-(2-methoxyethyl)borate.
• Continuous extraction purification method for intermediate isolation.
• Optimization of dimethoxytritylation using 2,6-lutidine as a base to improve 5 '/3 ' ratios and yield.
• Optimized conditions for conversion to the 5 -methylcytidine analog and isolation by crystallization.
• Selective hydrolysis method developed to remove benzoyl ester impurities during final benzoylation.

Main Results:

• Successfully produced 2 -O-(2-methoxyethyl)-5-methyluridine with improved yield and purity.
• Achieved enhanced 5 '/3 ' dimethoxytritylation ratios and overall yield through optimized conditions.
• Optimized the conversion and crystallization of the 5 -methylcytidine analog.
• Developed an effective method for selective hydrolysis of benzoyl ester impurities, improving final product quality.

Conclusions:

• The described process offers a more efficient and scalable route for the synthesis of 2 -O-(2-methoxyethyl)-pyrimidines.
• The optimized methods address key challenges in yield, purity, and impurity removal.
• This improved synthesis facilitates the production of valuable nucleoside analogs for further research and development.